Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Catalent - The Real Truth

FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles

The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate investigations, and insufficient corrective actions at the Novo Nordisk A/S (NYSE:NVO) operated facility in Bloomington, Indiana.

Benzinga

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% year-over-year, beating the consensus of $8.57.

Benzinga

Eli Lilly (LLY) vs. Catalent (CTLT): Which Pharma Stock Offers Better Returns?

The pharma industry is evolving rapidly due to the ever-rising healthcare needs and increasing demand for customized medicine and treatments worldwide. So, let’s analyze Eli Lilly (LLY) and Catalent (CTLT), to determine which pharma stock offers better returns. Read more.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Catalent Stock: Analyst Estimates & Ratings

Despite Catalent’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

What to Expect From Catalent's Next Quarterly Earnings Report

Catalent is expected to release its first-quarter earnings next month, and analysts expect a triple-digit profit surge.

Barchart

Catalent Stock: Is CTLT Outperforming the Healthcare Sector?

Despite Catalent’s outperformance relative to the broader sector, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Catalent Stock?

While Catalent has outperformed the broader market over the past year, analysts are cautious about the stock’s potential.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Weight-loss Drug Maker Novo Nordisk's Profits Soar Further

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.

International Business Times

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Barchart

Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?

Healthcare stocks LLY and NVO have crushed broader market returns in the past two decades. But with competition heating up over obesity drugs, which mega-cap stock is a better buy today?

Barchart

Novo Holdings Acquires Catalent for .5 Billion, Expands Wegovy Capacity

Novo Holdings has announced its acquisition of Catalent for .5 billion, a move aimed at expanding the production capacity of Wegovy, a drug used for obe...

Top News

Catalent (CTLT) Loses 6.1% Over the Past Month: Can the Stock Reverse Its Fortune?

Catalent, Inc. (CTLT) recently faced a setback, witnessing a 6.1% dip in its stock value over the last month. However, in the light of the recent release of its first quarter results of fiscal 2024, can the company reverse its fortune? Keep reading….

StockNews.com

Stocks Finish Higher Ahead of Wednesday’s FOMC Decision

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday rose by +0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose by +0.52%. Stocks on Tuesday closed moderately higher on mostly stronger-than-expected...

Barchart

Stocks Rally Off Morning Lows

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.37%. Stock indexes this afternoon are higher despite uneven corporate...

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Stocks Little Change after Mixed Corporate News and Weak Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.02%. Stock indexes this morning are mixed on uneven corporate...

Barchart

Stocks Modestly Lower on Higher Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.24%. U.S. stocks this morning are moderately lower as higher...

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours, at $101.06 per share. A move to $132.00 would account for a 30.62% increase from the current…

Benzinga

Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook

Catalent Inc (NYSE:CTLT) reported Q3 FY22 sales of $1.27 billion, +21% Y/Y as reported, or 23% in constant currency, edging out analysts' average expectation of $1.22 billion. Adjusted EPS of $1.04, compared to $0.82 last year, surpassed the consensus of $0.94. Adjusted EBITDA was $339 million, or a margin of 27%, compared…

Benzinga

Recap: Catalent Q3 Earnings

Catalent (NYSE:CTLT) reported its Q3 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

How To Attend Catalent Q3 2022 Earnings Conference Call

Catalent (NYSE:CTLT) will host a conference call at 08:15 AM ET on May 3, 2022, to discuss Q3 2022 earnings results. How to Attend Catalent (CTLT) Conference Call Follow this link to access the live webcast.

Daily Mirror

UK vaccine centre that got £205m from government is sold off to US pharma giant

Campaigners branded the sale of the Vaccine Manufacturing and Innovation Centre (VMIC) 'beyond absurd' as the UK faces the risk of a new Covid variant in the future

The Independent UK

Sale of UK vaccine manufacturing plant branded ‘ridiculously short-sighted’

US firm Catalent confirmed on Wednesday it had acquired the site in Oxfordshire.

Benzinga

Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance

Catalent Inc (NYSE: CTLT) has reported Q2 FY22 sales of $1.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.